Maria Fardis, Iovance CEO (file photo)
Hours after another FDA delay, Iovance CEO resigns — shares plummet
Here’s a good way to alarm investors: announce that the application for approval would be delayed by another year and then, less than 20 hours …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
